DelveInsight’s “Duchenne Muscular Dystrophy - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Duchenne Muscular Dystrophy for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Duchenne Muscular Dystrophy from 2010-2020.Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It affects approximately 1 in 3500 live male births throughout the world. There is no cure for DMD at this time, but there continues to be a tremendous amount of research taking place across the world. Researchers have made great advances in their knowledge of DMD and continue to search for a cure by new gene-based therapies such as conventional gene replacement strategies, RNA-based approaches, or cell-based gene therapy with a main focus on Duchenne muscular dystrophy (DMD).
Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
It also provides Market size of Duchenne Muscular Dystrophy for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
Note*: This report requires 5-10 business days to complete.